These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 15771412)

  • 1. Identification of substituted 6-amino-4-phenyltetrahydroquinoline derivatives: potent antagonists for the follicle-stimulating hormone receptor.
    van Straten NC; van Berkel TH; Demont DR; Karstens WJ; Merkx R; Oosterom J; Schulz J; van Someren RG; Timmers CM; van Zandvoort PM
    J Med Chem; 2005 Mar; 48(6):1697-700. PubMed ID: 15771412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First QSAR report on FSH receptor antagonistic activity: quantitative investigations on physico-chemical and structural features among 6-amino-4-phenyltetrahydroquinoline derivatives.
    Manivannan E; Prasanna S
    Bioorg Med Chem Lett; 2005 Oct; 15(20):4496-501. PubMed ID: 16085412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and pharmacological evaluation of dimeric follicle-stimulating hormone receptor antagonists.
    Bonger KM; Hoogendoorn S; van Koppen CJ; Timmers CM; Overkleeft HS; van der Marel GA
    ChemMedChem; 2009 Dec; 4(12):2098-102. PubMed ID: 19902448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, structure-activity relationship, and receptor pharmacology of a new series of quinoline derivatives acting as selective, noncompetitive mGlu1 antagonists.
    Mabire D; Coupa S; Adelinet C; Poncelet A; Simonnet Y; Venet M; Wouters R; Lesage AS; Van Beijsterveldt L; Bischoff F
    J Med Chem; 2005 Mar; 48(6):2134-53. PubMed ID: 15771457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tetrahydroquinoline derivatives as opioid receptor antagonists.
    Zhang C; Westaway SM; Speake JD; Bishop MJ; Goetz AS; Carballo LH; Hu M; Epperly AH
    Bioorg Med Chem Lett; 2011 Jan; 21(2):670-6. PubMed ID: 21193310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New 2-arylpyrazolo[3,4-c]quinoline derivatives as potent and selective human A3 adenosine receptor antagonists. Synthesis, pharmacological evaluation, and ligand-receptor modeling studies.
    Colotta V; Catarzi D; Varano F; Capelli F; Lenzi O; Filacchioni G; Martini C; Trincavelli L; Ciampi O; Pugliese AM; Pedata F; Schiesaro A; Morizzo E; Moro S
    J Med Chem; 2007 Aug; 50(17):4061-74. PubMed ID: 17665891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel vanilloid receptor-1 antagonists: 1. Conformationally restricted analogues of trans-cinnamides.
    Norman MH; Zhu J; Fotsch C; Bo Y; Chen N; Chakrabarti P; Doherty EM; Gavva NR; Nishimura N; Nixey T; Ognyanov VI; Rzasa RM; Stec M; Surapaneni S; Tamir R; Viswanadhan VN; Treanor JJ
    J Med Chem; 2007 Jul; 50(15):3497-514. PubMed ID: 17585749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-Alkylated thiazolidinones as follicle-stimulating hormone (FSH) receptor agonists.
    Wrobel J; Jetter J; Kao W; Rogers J; Di L; Chi J; Peréz MC; Chen GC; Shen ES
    Bioorg Med Chem; 2006 Aug; 14(16):5729-41. PubMed ID: 16675221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New 2-arylpyrazolo[4,3-c]quinoline derivatives as potent and selective human A3 adenosine receptor antagonists.
    Baraldi PG; Tabrizi MA; Preti D; Bovero A; Fruttarolo F; Romagnoli R; Zaid NA; Moorman AR; Varani K; Borea PA
    J Med Chem; 2005 Jul; 48(15):5001-8. PubMed ID: 16033279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A virtual screening approach to finding novel and potent antagonists at the melanin-concentrating hormone 1 receptor.
    Clark DE; Higgs C; Wren SP; Dyke HJ; Wong M; Norman D; Lockey PM; Roach AG
    J Med Chem; 2004 Jul; 47(16):3962-71. PubMed ID: 15267235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of quinolinyl and isoquinolinyl phenyl ketones as novel agonists for the cannabinoid CB2 receptor.
    Reux B; Nevalainen T; Raitio KH; Koskinen AM
    Bioorg Med Chem; 2009 Jul; 17(13):4441-7. PubMed ID: 19477133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Follicle stimulating hormone receptor (FSHR) antagonist and epithelial ovarian cancer (EOC).
    Bose CK
    J Exp Ther Oncol; 2007; 6(3):201-4. PubMed ID: 17552360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and characterization of nonsteroidal glucocorticoid receptor modulators for multiple myeloma.
    Hudson AR; Roach SL; Higuchi RI; Phillips DP; Bissonnette RP; Lamph WW; Yen J; Li Y; Adams ME; Valdez LJ; Vassar A; Cuervo C; Kallel EA; Gharbaoui CJ; Mais DE; Miner JN; Marschke KB; Rungta D; Negro-Vilar A; Zhi L
    J Med Chem; 2007 Sep; 50(19):4699-709. PubMed ID: 17705362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tetrahydroquinoline sulfonamides as vasopressin 1b receptor antagonists.
    Scott JD; Miller MW; Li SW; Lin SI; Vaccaro HA; Hong L; Mullins DE; Guzzi M; Weinstein J; Hodgson RA; Varty GB; Stamford AW; Chan TY; McKittrick BA; Greenlee WJ; Priestley T; Parker EM
    Bioorg Med Chem Lett; 2009 Nov; 19(21):6018-22. PubMed ID: 19800231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and synthesis of novel sulfonamide-containing bradykinin hB2 receptor antagonists. 1. Synthesis and SAR of alpha,alpha-dimethylglycine sulfonamides.
    Fattori D; Rossi C; Fincham CI; Berettoni M; Calvani F; Catrambone F; Felicetti P; Gensini M; Terracciano R; Altamura M; Bressan A; Giuliani S; Maggi CA; Meini S; Valenti C; Quartara L
    J Med Chem; 2006 Jun; 49(12):3602-13. PubMed ID: 16759102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and characterization of 5,6,7,8-tetrahydroquinoline C5a receptor antagonists.
    Barbay JK; Gong Y; Buntinx M; Li J; Claes C; Hornby PJ; Van Lommen G; Van Wauwe J; He W
    Bioorg Med Chem Lett; 2008 Apr; 18(8):2544-8. PubMed ID: 18378452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 6-Acylamino-2-amino-4-methylquinolines as potent melanin-concentrating hormone 1 receptor antagonists: structure-activity exploration of eastern and western parts.
    Ulven T; Little PB; Receveur JM; Frimurer TM; Rist O; Nørregaard PK; Högberg T
    Bioorg Med Chem Lett; 2006 Feb; 16(4):1070-5. PubMed ID: 16289819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of peptide 20-30 of follicle stimulating hormone receptor as an antagonist of receptor activity: significance of charged residues.
    Dupakuntla M; Ghosalkar JD; Mahale SD
    Chem Biol Drug Des; 2009 Jan; 73(1):108-14. PubMed ID: 19152639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacomodulations around the 4-oxo-1,4-dihydroquinoline-3-carboxamides, a class of potent CB2-selective cannabinoid receptor ligands: consequences in receptor affinity and functionality.
    Stern E; Muccioli GG; Bosier B; Hamtiaux L; Millet R; Poupaert JH; Hénichart JP; Depreux P; Goossens JF; Lambert DM
    J Med Chem; 2007 Nov; 50(22):5471-84. PubMed ID: 17915849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel isoxazole carboxamides as growth hormone secretagogue receptor (GHS-R) antagonists.
    Liu B; Liu G; Xin Z; Serby MD; Zhao H; Schaefer VG; Falls HD; Kaszubska W; Collins CA; Sham HL
    Bioorg Med Chem Lett; 2004 Oct; 14(20):5223-6. PubMed ID: 15380232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.